Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
XORTX Therapeutics Inc. (XRTX) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.72M |
|
-- |
|
-- |
|
$0.89M |
|
$-0.89M |
|
$0.17M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.89M |
|
$-0.86M |
|
3.79M |
|
3.79M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$1.26M |
|
$0.08M |
|
$1.48M |
|
$2.74M |
|
$0.71M |
|
-- |
|
-- |
|
$0.71M |
|
$2.03M |
|
$1.84M |
|
$2.03M |
|
3.79M |
|
| Cash Flow Statement Financials | |
$-1.44M |
|
$-0.03M |
|
$0.02M |
|
$2.47M |
|
$1.06M |
|
$-1.41M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.78 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.34% |
|
-39.10% |
|
-26.17% |
|
-35.34% |
|
$0.54 |
|
$-0.38 |
|
$-0.38 |
|